Tone Sandal

1.4k total citations
16 papers, 1.1k citations indexed

About

Tone Sandal is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Tone Sandal has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Tone Sandal's work include Phagocytosis and Immune Regulation (5 papers), Pancreatic function and diabetes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Tone Sandal is often cited by papers focused on Phagocytosis and Immune Regulation (5 papers), Pancreatic function and diabetes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Tone Sandal collaborates with scholars based in Norway, United States and Denmark. Tone Sandal's co-authors include Bjørn Tore Gjertsen, James B. Lorens, David Micklem, Hallvard Haugen, Shan Li, Torill Høiby, Christine Gjerdrum, Carlotta A. Glackin, Emmet McCormack and Karin Collett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Tone Sandal

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tone Sandal Norway 13 488 430 410 174 145 16 1.1k
Derek L. Dai Canada 14 629 1.3× 292 0.7× 179 0.4× 205 1.2× 115 0.8× 18 1.0k
Susana Constantino Rosa Santos Portugal 17 664 1.4× 464 1.1× 224 0.5× 68 0.4× 250 1.7× 41 1.3k
Birgit Bossenmaier Germany 19 807 1.7× 816 1.9× 281 0.7× 179 1.0× 87 0.6× 42 1.8k
Lucia Fallavollita Canada 17 669 1.4× 685 1.6× 292 0.7× 109 0.6× 421 2.9× 23 1.5k
Mikinori Sato Japan 19 603 1.2× 704 1.6× 214 0.5× 239 1.4× 302 2.1× 59 1.4k
Marco Arndt Germany 16 600 1.2× 607 1.4× 120 0.3× 100 0.6× 232 1.6× 37 1.7k
Hany Kayed Germany 23 923 1.9× 640 1.5× 141 0.3× 233 1.3× 263 1.8× 45 1.5k
Janet Glassford United Kingdom 16 972 2.0× 423 1.0× 302 0.7× 58 0.3× 178 1.2× 22 1.5k
Takatomo Koshiba Japan 16 658 1.3× 856 2.0× 333 0.8× 196 1.1× 318 2.2× 29 1.5k
Helen Kotanides United States 12 757 1.6× 486 1.1× 322 0.8× 54 0.3× 260 1.8× 16 1.2k

Countries citing papers authored by Tone Sandal

Since Specialization
Citations

This map shows the geographic impact of Tone Sandal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tone Sandal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tone Sandal more than expected).

Fields of papers citing papers by Tone Sandal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tone Sandal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tone Sandal. The network helps show where Tone Sandal may publish in the future.

Co-authorship network of co-authors of Tone Sandal

This figure shows the co-authorship network connecting the top 25 collaborators of Tone Sandal. A scholar is included among the top collaborators of Tone Sandal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tone Sandal. Tone Sandal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kirane, Amanda, Kathleen Ludwig, Noah Sorrelle, et al.. (2015). Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Research. 75(18). 3699–3705. 108 indexed citations
2.
Tiron, Crina, Gro Gausdal, Tone Sandal, et al.. (2014). Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies. Cancer Research. 74(19_Supplement). 1747–1747. 12 indexed citations
3.
Gausdal, Gro, Tone Sandal, Stefan Hinz, et al.. (2014). Abstract B30: Selective small molecule AXL inhibitor BGB324 overcomes acquired drug resistance in non-small cell lung carcinoma models.. Clinical Cancer Research. 20(2_Supplement). B30–B30. 1 indexed citations
4.
Pörksen, Sven, Lene Bjerke Laborie, Lotte B. Nielsen, et al.. (2010). Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies. BMC Endocrine Disorders. 10(1). 16–16. 15 indexed citations
5.
Sandal, Tone, et al.. (2009). The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clinical Genetics. 75(5). 440–448. 30 indexed citations
6.
Gjerdrum, Christine, Crina Tiron, Torill Høiby, et al.. (2009). Abstract B105: Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Molecular Cancer Therapeutics. 8(12_Supplement). B105–B105. 1 indexed citations
7.
Gjerdrum, Christine, Crina Tiron, Torill Høiby, et al.. (2009). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proceedings of the National Academy of Sciences. 107(3). 1124–1129. 458 indexed citations
8.
Chekenya, Martha, Camilla Krakstad, Agnete Svendsen, et al.. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene. 27(39). 5182–5194. 127 indexed citations
9.
Christesen, Henrik Thybo, Nicholas D. Tribble, Anders Molven, et al.. (2008). Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.. European Journal of Endocrinology. 159(1). 27–34. 69 indexed citations
10.
Sandal, Tone, Klara Valyi‐Nagy, Virginia A. Spencer, et al.. (2007). Epigenetic Reversion of Breast Carcinoma Phenotype Is Accompanied by Changes in DNA Sequestration as Measured by AluI Restriction Enzyme. American Journal Of Pathology. 170(5). 1739–1749. 20 indexed citations
11.
Folberg, Robert, Zarema Arbieva, Tone Sandal, et al.. (2006). Tumor Cell Plasticity in Uveal Melanoma. American Journal Of Pathology. 169(4). 1376–1389. 52 indexed citations
12.
Sandal, Tone, et al.. (2003). Irod/Ian5: An Inhibitor of γ-Radiation- and Okadaic Acid-induced Apoptosis. Molecular Biology of the Cell. 14(8). 3292–3304. 53 indexed citations
13.
Sandal, Tone. (2002). Molecular Aspects of the Mammalian Cell Cycle and Cancer. The Oncologist. 7(1). 73–81. 97 indexed citations
14.
Sandal, Tone, Camilla Stapnes, Hans Kleivdal, Lars O. Hedin, & Stein Ove Døskeland. (2002). A Novel, Extraneuronal Role for Cyclin-dependent Protein Kinase 5 (CDK5). Journal of Biological Chemistry. 277(23). 20783–20793. 50 indexed citations
15.
Sandal, Tone, Åsa Rydén Ahlgren, J.R. Lillehaug, & Stein Ove Døskeland. (2001). Establishment of okadaic acid resistant cell clones using a cDNA expression library. Cell Death and Differentiation. 8(7). 754–766. 18 indexed citations
16.
Sandal, Tone, et al.. (2001). Establishment of Okadaic Acid Resistant Cell Clones using CDNA Library Expression Cloning. The Scientific World JOURNAL. 1. 42–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026